Pain Management

His relationship with primary care physicians is one of the most important, says physiatrist DJ Kennedy, MD, and he lists the reasons in this interview.

RiVive™ nasal spray is the second nonprescription naloxone product approved by the FDA for the emergency treatment of opioid overdose.

Physiatrist DJ Kennedy, MD, is excited by the potential for new, and even existing technology, to present novel options for diagnosis, monitoring, and treatment.

A daily dose of clinical news on Patient Care you may have missed.

When is a primary care patient with back pain ready for referral to PM&R? No formulas available but basic principles hold true and earlier is always better.

The challenge posed by a complaint of back pain is not that the origin is unknowable but rather the remarkable heterogeneity in this condition, says the president-elect of the American Academy of Physical Medicine & Rehabilitation.

Your daily dose of clinical news you may have missed.

Results showed that the use of opioid analgesics did not confer any benefits for adults with acute low back pain or neck pain compared to placebo.

Is there evidence to support hypnosis for pediatric pain? A new review examined available studies to find out.

Your daily dose of clinical news you may have missed.

Brixadi is the first and only long-acting buprenorphine injectable that is available in both weekly and monthly doses.

A recent CDC report showed that approximately 20% of Americans experienced chronic pain in 2021 and certain groups were most vulnerable. Details in our new slideshow.

Your daily dose of clinical news you may have missed.

Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.

Your daily dose of clinical news you may have missed.

Medicinal cannabis products reduced use of opioids and other medications and products that contained balanced measures of THC and CBD appeared most effective.

The role of the trigeminal nerve and its connection to the brainstem has led to a greater understanding of where migraine pain originates. Expert explains, here.

A family physician and obesity medicine physician talks about chronic pain in patients with obesity.

Statins in AF patients cut risk of TIA; opioid makers must strengthen label warnings; individualized Rx reduces BP; and 2 more research quotes of note.

Use of opioids to manage chronic pain is not preferred but the VA/DoD make specific new recommendations on how to proceed. Try 8 questions on the guidelines.

The oral calcitonin gene-related peptide receptor antagonist is now indicated for prevention in both episodic and chronic migraine.

Although the number of dispensed opioid prescriptions has somewhat declined, overdose deaths involving opioids continue to rise. The FDA is requiring stronger warnings of risk.

To be marketed as Rizafilm, the product is a disintegrating film formulation of the 5-HT-1 receptor antagonist and proven bioequivalent to Merck's Maxalt-MLT.

Chronic and chronic high-impact pain disproportionately affect AI/AN populations, gay and lesbian adults, and separated or divorced individuals, according to new data.

Migraine disproportionately affects women, a disparity typically ascribed to hormonal differences. A new study takes a new look at the issue.

Among other improvements, bariatric surgery may help reverse peripheral neuropathy and stabilize cardiovascular autonomic neuropathy, according to new findings.

Your daily dose of clinical news you may have missed.

Updated VA/DoD chronic pain management guidelines include recommendations for dual use of buprenorphine and increased mental health assessment before prescribing opioids.

Pain is a prominent symptom among persons with COPD yet management is not included in clinical guidelines and current research findings are vague, say study authors.

High salt intake linked to coronary atherosclerosis; daily ETOH, even in small doses, is dangerous; statins don't increase muscle injury; and 2 more studies of note.